News
1d
Zacks Investment Research on MSNADMA vs Takeda: Which Plasma Therapy Stock Is the Better Buy Today?ADMA Biologics ADMA and Takeda TAK are leading players in the plasma derived immunoglobulin sector. ADMA markets ...
Takeda (TOKYO:4502/NYSE:TAK) has announced new assignments of directors, determined at the Board of Directors meeting, following the 149th Annual Meeting of Shareholders, held in Osaka today.
Protagonist Therapeutics Inc. (NASDAQ:PTGX) is one of the best mid cap growth stocks to invest in now. Just as June began, ...
Takeda is the latest major pharmaceutical company to increase its investments in the U.S. market, partly in response to President Donald Trump’s potential tariffs. The company’s CEO, Christophe Weber, ...
OSAKA, Japan and CAMBRIDGE, Massachusetts, April 25, 2025 – Takeda (TSE:4502/NYSE:TAK) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...
Behind luxury condos and Harvard’s shadow was an elite brothel for the ultrarich, complete with background checks for a USD 600-an-hour 'girlfriend experience'. An Indian-origin CEO is among its long ...
Takeda Pharmaceutical has hired Jane Woo as VP and head of research and development and portfolio communications, ... Woo is based in Takeda’s U.S. hub in Cambridge, Massachusetts. “A big part of ...
Massachusetts’ largest pharmaceutical company is laying off employees again The cuts will total close to 1,000 employees for this year and next. Takeda building in Cambridge. David L Ryan, Globe ...
Takeda Pharmaceutical Inc., Massachusetts’ largest biotech company, announced a second round of layoffs late last month bringing the total number of employees affected to 861 in 2024, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results